XML 48 R35.htm IDEA: XBRL DOCUMENT v3.22.1
ACQUISITIONS AND DIVESTITURES - Pro Forma Information (Details) - Cognate BioServices, Inc. and Viegene Biosciences, Inc.
$ in Thousands
3 Months Ended
Mar. 26, 2022
USD ($)
Business Acquisition [Line Items]  
Revenue $ 858,800
Net income attributable to common shareholders $ 37,575